Published by Josh White on 26th August 2025
(Sharecast News) - ValiRx announced a new wholly owned subsidiary Blue Ribbon Bio on Tuesday, to consolidate its prostate cancer assets and accelerate development of its Val201 peptide therapy.
URL: http://www.digitallook.com/dl/news/story/35309928/...